Beyond Borders: UK–Japan Discovery Pitch

We are delighted to introduce a unique cross-border pitch event co-hosted by the Francis Crick Institute, KQ Labs, and MEDISO Direct Flight, where Japanese and UK life science startups take the stage in turn to showcase their breakthrough innovations and inspire each other.

This event celebrates the dynamic partnership between Japan and the UK — two nations renowned for their creativity and scientific excellence in biotechnology and healthcare innovation.

Through a series of short, alternating pitches, each company will share its cutting-edge science, bold vision, and global ambitions before an audience of investors, corporates, and ecosystem partners.

More than just a showcase, this session is a collaborative exchange — a chance for startups from both countries to learn from one another, spark new ideas, and build lasting connections that could lead to joint research, co-development, and future investment.

Together, we aim to strengthen the bridge between the Japanese and UK innovation ecosystems, accelerating the journey from discovery to impact on a truly global scale.

Info: AI · Radiology · Clinical Trials
Developing “Radii,” an AI-driven radiology and patient-matching platform to accelerate clinical trial recruitment, particularly for CNS and oncology studies.

Info: Clinical Trials · AI · Digital Platform
An “anti-CRO” using AI and digital tools to deliver faster, more cost-effective clinical trials, transforming how biotech and pharma companies run studies.

Info: Metabolism · Down Syndrome · CNS Therapy
Creating a first-in-class oral therapy that restores energy metabolism to treat hypotonia in children with Down syndrome and other neuromuscular disorders.

Info: Healthy Ageing · Cell Death · Regeneration: Targeting necrosis as a key driver of ageing and organ failure, LinkGevity develops therapeutics to extend healthspan and resilience.

Info: Drug Delivery · Nose-to-Brain · CNS
Developing a proprietary non-invasive “nose-to-brain” drug delivery system, enabling safe and efficient CNS therapies.

Info: Aptamers · AI Drug Discovery · Molecular Design
Combining AI and wet-lab experimentation to create next-generation aptamer-based therapeutics and diagnostics with high specificity.

Info: AI · Spatial Omics · Precision Medicine
Providing an AI-powered spatial analysis platform that accelerates biomarker discovery and patient stratification for precision medicine.

Know what’s Happening Next — before everyone else does.

Get App

Host or Publisher Biospire UK Limited